id: pea_administration_to_allergic_rhinitis_symptoms
name: Palmitoylethanolamide (PEA) Administration â†’ Allergic Rhinitis Symptoms
from_node:
  node_id: pea_administration
  node_name: Palmitoylethanolamide (PEA) Administration
to_node:
  node_id: allergic_rhinitis_symptoms
  node_name: Allergic Rhinitis Symptoms
direction: negative
category: biological
mechanism_pathway:
- 'Step 1: PEA is administered to mice with ovalbumin-induced allergic rhinitis'
- 'Step 2: PEA suppresses Th2 cell differentiation which drives allergic responses'
- 'Step 3: Reduced Th2 responses decrease inflammatory mediator production'
- 'Step 4: Decreased inflammation leads to alleviation of allergic rhinitis symptoms'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Yasuhiro Soga et al. 2025. "Lipid mediator palmitoylethanolamide
    (PEA) inhibits pathogenic T cell differentiation in vitro and in vivo.." *Biochemical
    and biophysical research communications*. https://doi.org/10.1016/j.bbrc.2024.151085
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.111903'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
